Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis

被引:0
|
作者
Mariaelena Pierobon
Cara L. Frankenfeld
机构
[1] George Mason University,Department of Global and Community Health
来源
关键词
Triple-negative breast cancer; Obesity; Systematic review; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Triple-negative breast cancer (TNBC) is a subtype of breast tumor with unique characteristics in terms of clinical−pathological presentation, prognosis, and response to therapy. Epidemiological investigations focusing on the identification of risk factors involved in the onset and progression of TNBCs have identified unique demographic, anthropometric, and reproductive characteristics involved in the etiopathogenesis of this subtype of breast tumors. This systematic review and meta-analysis evaluates the association between TNBCs and obesity and menopause status. Eligible articles were identified through three databases and secondary reference analysis. The search was conducted from the first record to February 2012. Eleven original articles meeting a priori established inclusion criteria were incorporated in the quantitative analysis. Case−case and case–control comparisons were performed. In addition, a case–case comparison was conducted before and after stratification according to menopausal status. Based on the level of between-study heterogeneity, pooled odds ratio (OR) and 95 % confidence interval were calculated using fixed or random models. The case−case comparison showed a significant association between TNBC and obesity (OR: 1.20; 95 % CI: 1.03−1.40). These results were confirmed by the case–control comparison (OR: 1.24; 95 % CI: 1.06−1.46). Once stratification based on menopausal status was applied to the case–case analysis, significant results were observed only in the pre-menopausal group (OR: 1.43; 95 % CI: 1.23−1.65). According to this analysis, obese women are at a greater risk of presenting with a TNBC than non-obese women, and menopause status may be a mitigating factor. If validated, these findings should be taken into consideration for the development of targeted preventive programs.
引用
收藏
页码:307 / 314
页数:7
相关论文
共 50 条
  • [21] Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis
    Poggio, F.
    Bruzzone, M.
    Ceppi, M.
    Ponde, N. F.
    La Valle, G.
    Del Mastro, L.
    de Azambuja, E.
    Lambertini, M.
    ANNALS OF ONCOLOGY, 2018, 29 (07) : 1497 - 1508
  • [22] Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis
    Petrelli, Fausto
    Ghidini, Antonio
    Rea, Carmen
    Parati, Maria Chiara
    Borgonovo, Karen
    Ghidini, Michele
    Ruatta, Fiorella
    Zaniboni, Alberto
    Luciani, Andrea
    Garrone, Ornella
    Tomasello, Gianluca
    CURRENT PROBLEMS IN CANCER, 2024, 50
  • [23] Platinum-based neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
    Li, Zhen-Yu
    Zhang, Zhen
    Cao, Xiao-Zhong
    Feng, Yun
    Ren, Sha-Sha
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (10)
  • [24] Triple-negative breast cancers
    Narod, Steven A.
    Dent, Rebecca
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (10) : 1041 - 1043
  • [25] Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysis
    Shi, Mingqiang
    Li, Zhoujuan
    Wang, Tianzhuo
    Wang, Miaozhou
    Liu, Zhen
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (02): : 91 - 98
  • [26] Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
    Liu, Xu
    Wu, Kan
    Zheng, Dan
    Luo, Chuanxu
    Fan, Yu
    Zhong, Xiaorong
    Zheng, Hong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Immune checkpoint inhibitors as neoadjuvant therapy in early triple-negative breast cancer: A systematic review and meta-analysis
    Mittal, Niti
    Singh, Surjit
    Mittal, Rakesh
    Kaushal, Jyoti
    Kaushal, Vivek
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1754 - +
  • [28] Platinum-based chemotherapy for early triple-negative breast cancer: A Cochrane systematic review and meta-analysis
    Mason, Sofia
    Willson, Melina
    Goodwin, Annabel
    Beith, Jane
    Egger, Sam J.
    Dear, Rachel F.
    CANCER RESEARCH, 2023, 83 (05)
  • [29] Atezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis
    Latif, Farah
    Jabbar, Hira Bint Abdul
    Malik, Hamna
    Sadaf, Humaira
    Sarfraz, Azza
    Sarfraz, Zouina
    Cherrez-Ojeda, Ivan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (02) : 229 - 235
  • [30] Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
    Guenancia, Charles
    Lefebvre, Annick
    Cardinale, Daniela
    Yu, Anthony F.
    Ladoire, Sylvain
    Ghiringhelli, Francois
    Zeller, Marianne
    Rochette, Luc
    Cottin, Yves
    Vergely, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26) : 3157 - +